IQVIA Holdings Inc.

IQVNYSE • USD
265.12 USD
↘ 5.99 (2.21%)AT CLOSE (03:59 PM EST)
265.07
↘ 0.05 (0.02%)
POST MARKET (AS OF 07:53 PM EST)
Post Market
AS OF 07:53 PM EST
265.07
↘ 0.05 (0.02%)
🔴Market: CLOSED

IQVIA Holdings Inc. (IQV) trades at $265.12 per share. IQV shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Sell". Notable factors include a robust Altman Z-Score, exceptional Return on Equity (20.9%) and a bullish Golden Cross on the moving averages. Valuation metrics place IQV at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$271.72
High?$272.12
Low?$263.50
Prev. Close?$271.11
Volume?2.0M
Avg. Volume?1.4M
VWAP?$266.02
Rel. Volume?1.46x
Bid / Ask
Bid?$260.60 × 40
Ask?$270.29 × 40
Spread?$9.69
Midpoint?$265.45
Valuation & Ratios
Market Cap?44.7B
Shares Out?164.8M
Float?149.6M
Float %?90.9%
P/E Ratio?32.05
P/B Ratio?6.71
EPS?$8.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Employees
95.0K
Market Cap
44.7B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2013-05-09
Address
2400 ELLIS ROAD
DURHAM, NC 27703
Phone: 919-998-2000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
73
Momentum?
62
Short Sent.?
64
Piotroski F-Score?6/9Mixed
Altman Z-Score?3.07Safe
Confidence?83%High
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.03%Low
Short Interest?3.0M
Days to Cover?2.1
Free Float149.6M
Avg Daily Volume1.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?0.83Weak
Quick Ratio?0.83Weak
Cash Ratio?0.29Low
Debt/Equity?2.41High
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
67/100
P/E?
Peers
100
S&P
28
32.1PRICEY▾
P/B?
Peers
36
S&P
28
6.71FAIR▾
P/S?
Peers
100
S&P
56
2.58CHEAP▾
P/FCF?
Peers
100
S&P
50
21.5FAIR▾
EV/EBITDA?
Peers
100
S&P
42
16.2FAIR▾
EV/Sales?
Peers
100
S&P
55
3.38FAIR▾
Returns & Efficiency
ROE?
Peers
82
S&P
68
20.9%STRONG▾
ROA?
Peers
36
S&P
41
4.6%FAIR▾
Cash Flow & Enterprise
FCF?$2.1B
Enterprise Value?$58.5B
Fundamentals ratios updated end of day